<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmaceuticalcommerce.com/view/executive-conversations-how-patient-advocacy-is-shaping-channel-design</loc>
      <lastmod>2026-11-20T16:46:22.494Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Commerce</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T16:46:22.494Z</news:publication_date>
        <news:title><![CDATA[Executive Conversations: How Patient Advocacy Is Shaping Channel Design]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmaceuticalcommerce.com/view/how-specialty-trade-deals-are-shifting-toward-patients</loc>
      <lastmod>2026-11-20T14:07:26.898Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Commerce</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T14:07:26.898Z</news:publication_date>
        <news:title><![CDATA[How Specialty Trade Deals Are Shifting Toward Patients]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmaceuticalcommerce.com/view/executive-conversations-how-should-manufacturers-reevaluate-their-channel-strategy</loc>
      <lastmod>2026-11-19T19:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Commerce</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Executive Conversations: How Should Manufacturers Reevaluate Their Channel Strategy?]]></news:title>
      </news:news>
	</url></urlset>